Alterity Therapeutics (ATHE) has released an update.
Alterity Therapeutics Limited announced the expiration of 12 million options, coded ATHAAF, priced at $0.07, which were not exercised or converted by the deadline of July 31, 2024. The cessation of these securities does not involve any consideration from the entity. Following this change, the company has updated its issued capital information, excluding the expired options from its records.
For further insights into ATHE stock, check out TipRanks’ Stock Analysis page.
